Estradiol transdermal - Elan Pharma
Alternative Names: Elleste Solo MX; Femanest; FematrixLatest Information Update: 19 Dec 2021
Price :
$50 *
At a glance
- Originator Elan Pharma International
- Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Menopausal syndrome; Postmenopausal osteoporosis
Most Recent Events
- 02 Jan 2013 Abbott separates its pharmaceuticals business to new company called AbbVie
- 16 Oct 2009 Wyeth has been acquired by Pfizer
- 30 Jun 2004 Durascan has been acquired by Sandoz